OmarYumenMD

PubMed

• 48 citations
  The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial.
  Joanne B. Weidhaas, Jonathan Harris, Dörthe Schaue, Allen M. Chen, Robert Chin, Rita Axelrod, Adel K. El-Naggar, Anurag K. Singh, Thomas J. Galloway, David Raben, Dian...> ;JAMA Oncology. 2017 Apr 1
• Dosimetric differences between intraoperative and postoperative plans using Cs-131 in transrectal ultrasound–guided brachytherapy for prostatic carcinoma
  Andrew O. Jones, J Treas, Brian Yavoich, Douglas Dean, John Danella, Omar Yumen> ;Medical Dosimetry. 2014 Dec 1
• 17 citations
  Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma...
  Amy Law, Thomas L. Kennedy, Phillip K. Pellitteri, Craig Wood, Douglas Christie, Omar Yumen> ;International Journal of Radiation Oncology, Biology, Physics. 2007 Dec 1
• 43 citations
  Breast Cancer in Elderly Women: Outcome as Affected by Age, Tumor Features, Comorbidities, and Treatment Approach
  Nava Siegelmann-Danieli, Vivek Khandelwal, G. Craig Wood, Roshan Mainali, Jeffrey W. Prichard, Timothy J. Murphy, James F. Evans, Omar Yumen, Albert M. Bernath> ;Clinical Breast Cancer. 2006 Apr 1
• 4 citations
  Burkitt's lymphoma presenting as ophthalmoplegia in an elderly male.
  Shervl A. Russ, Omar Yumen> ;American Journal of Hematology. 1994 Jan 1
• 45 citations
  Plasmapheresis. A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis.
  James O. Brady, John A. Riccio, Omar Yumen, Adel Z. Makary, Steven M. Greenwood> ;American Journal of Clinical Pathology. 1991 Sep 1
• Join now to see all